Senti Biosciences Holdings (SNTI) Return on Assets (2021 - 2025)

Senti Biosciences Holdings (SNTI) posted quarterly Return on Assets of 0.04% for Q4 2025, down 145.13% quarter-over-quarter from 0.02% in Q3 2025.

Senti Biosciences Holdings (SNTI) Return on Assets (2021 - 2025) Analysis & Trends

Senti Biosciences Holdings' Return on Assets history runs 5 years deep, the most recent figure standing at 0.04% for Q4 2025.

In Q4 2025, Return on Assets changed N/A year-over-year to 0.04%; the TTM figure through Dec 2025 stood at 0.04% (changed N/A YoY), while the FY2025 annual figure was 0.02%, changed N/A from the prior year.
Return on Assets for Q4 2025 stood at 0.04%, down from 0.02% in the prior quarter.
The five-year high for Return on Assets was 0.0% in Q2 2024, with the low at 0.04% in Q4 2025.
The 5-year median for Return on Assets is 0.0% (2021), against an average of 0.01%.
The sharpest annual moves came in 2023 and 2025: Return on Assets rose 1 bps in 2023, then declined 2 bps in 2025.
Senti Biosciences Holdings' Return on Assets stood at 0.0% in 2021, then slumped by 72 bps to 0.01% in 2022, then soared by 117 bps to 0.0% in 2023, then tumbled by 100 bps to 0.0% in 2024, then tumbled by 1113151 bps to 0.04% in 2025.
Business Quant data shows SNTI's Return on Assets at 0.04% in Q4 2025, 0.02% in Q3 2025, and 0.01% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	0.00%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.00%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.00%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.00%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	0.00%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.00%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.00%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.00%
10	Senti Biosciences Holdings	12.06 Mn	12.06 Mn	-	-0.02%

Download Data